Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Liang

Showing results (191-200 of 269) with videos related to

Pageof 27
Sort By:
Molecular Imaging|September 25, 2014
First human use of a radiopharmaceutical prepared by continuous-flow microfluidic radiofluorination: proof of concept with the tau imaging agent [18F]T807Steven H Liang, Daniel L Yokell, Marc D Normandin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 29, 2015
18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 ExpressionOrit Jacobson, Ido D Weiss, Lu Wang, et al.
Acta Pharmaceutica Sinica. B|September 23, 2024
Discovery and evaluation of a novel <sup>18</sup>F-labeled vasopressin 1a receptor PET ligand with peripheral binding specificityJunqi Hu, Yinlong Li, Chenchen Dong, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2020
Synthesis and pharmacokinetic study of a <sup>11</sup>C-labeled cholesterol 24-hydroxylase inhibitor using 'in-loop' [<sup>11</sup>C]CO<sub>2</sub> fixation methodZhen Chen, Jiahui Chen, Natalia Mast, et al.
International Journal of Medicinal Chemistry|December 5, 2017
Fluorinated Adenosine A<sub>2A</sub> Receptor Antagonists Inspired by Preladenant as Potential Cancer ImmunotherapeuticsGengyang Yuan, Tanner C Jankins, Christopher G Patrick, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Evaluation of [<sup>18</sup>F]Favipiravir in Rodents and Nonhuman Primates (NHP) with Positron Emission TomographyJian Rong, Chunyu Zhao, Xiaotian Xia, et al.
Journal of Neurochemistry|August 31, 2023
Differential responses of disease-related GRIN variants located in pore-forming M2 domain of N-methyl-D-aspartate receptor to FDA-approved inhibitorsRui Song, Jin Zhang, Riley E Perszyk, et al.
Acta Pharmaceutica Sinica. B|March 1, 2021
Recent developments on PET radiotracers for TSPO and their applications in neuroimagingLingling Zhang, Kuan Hu, Tuo Shao, et al.
Journal of Medicinal Chemistry|March 3, 2020
Discovery and Optimization of α-Mangostin Derivatives as Novel PDE4 Inhibitors for the Treatment of Vascular DementiaJinhao Liang, Yi-You Huang, Qian Zhou, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Radiosynthesis and Evaluation of <sup>18</sup>F‑Labeled Deuterated Radioligand for Positron Emission Tomography Imaging of Cholesterol 24-HydroxylaseYinlong Li, Zhendong Song, Haofeng Shi, et al.
Pageof 27

Showing results (191-200 of 269) with videos related to

Sort By:
Pageof 27
Molecular Imaging|September 25, 2014
First human use of a radiopharmaceutical prepared by continuous-flow microfluidic radiofluorination: proof of concept with the tau imaging agent [18F]T807Steven H Liang, Daniel L Yokell, Marc D Normandin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 29, 2015
18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 ExpressionOrit Jacobson, Ido D Weiss, Lu Wang, et al.
Acta Pharmaceutica Sinica. B|September 23, 2024
Discovery and evaluation of a novel <sup>18</sup>F-labeled vasopressin 1a receptor PET ligand with peripheral binding specificityJunqi Hu, Yinlong Li, Chenchen Dong, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2020
Synthesis and pharmacokinetic study of a <sup>11</sup>C-labeled cholesterol 24-hydroxylase inhibitor using 'in-loop' [<sup>11</sup>C]CO<sub>2</sub> fixation methodZhen Chen, Jiahui Chen, Natalia Mast, et al.
International Journal of Medicinal Chemistry|December 5, 2017
Fluorinated Adenosine A<sub>2A</sub> Receptor Antagonists Inspired by Preladenant as Potential Cancer ImmunotherapeuticsGengyang Yuan, Tanner C Jankins, Christopher G Patrick, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Evaluation of [<sup>18</sup>F]Favipiravir in Rodents and Nonhuman Primates (NHP) with Positron Emission TomographyJian Rong, Chunyu Zhao, Xiaotian Xia, et al.
Journal of Neurochemistry|August 31, 2023
Differential responses of disease-related GRIN variants located in pore-forming M2 domain of N-methyl-D-aspartate receptor to FDA-approved inhibitorsRui Song, Jin Zhang, Riley E Perszyk, et al.
Acta Pharmaceutica Sinica. B|March 1, 2021
Recent developments on PET radiotracers for TSPO and their applications in neuroimagingLingling Zhang, Kuan Hu, Tuo Shao, et al.
Journal of Medicinal Chemistry|March 3, 2020
Discovery and Optimization of α-Mangostin Derivatives as Novel PDE4 Inhibitors for the Treatment of Vascular DementiaJinhao Liang, Yi-You Huang, Qian Zhou, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Radiosynthesis and Evaluation of <sup>18</sup>F‑Labeled Deuterated Radioligand for Positron Emission Tomography Imaging of Cholesterol 24-HydroxylaseYinlong Li, Zhendong Song, Haofeng Shi, et al.
Pageof 27